SCHEMBL1679277

SCHEMBL1679277

COC(=O)Cc1ccc(-c2ccc(OCc3ccc(C(C)C)c(O)c3C(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 10/20 0.60
NR1H3 Q13133 8/20 0.60
RXRA P19793 9/20 0.48
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTGER4 P35408 1/20 0.37
ADAMTS4 O75173 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
BCL2 P10415 1/20 0.35
ESR1 P03372 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
VDR P11473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1679246 0.90 NR1H2 (0.73) NR1H2NR1H3RXRAPTGER4ADAMTS4
SCHEMBL1678839 0.87 NR1H2 (0.69) NR1H2NR1H3RXRANPC1ALDH1A1
SCHEMBL1678804 0.87 NR1H2 (0.61) NR1H2NR1H3RXRANPC1ALDH1A1
SCHEMBL1679093 0.85 NR1H2 (0.82) NR1H2NR1H3RXRANPC1ALDH1A1
SCHEMBL1678788 0.83 NR1H2 (0.63) NR1H2NR1H3RXRAMEN1KMT2A
SCHEMBL1679300 0.78 NR1H2 (0.50) NR1H2NR1H3RXRANPC1ALDH1A1
SCHEMBL1679003 0.78 NR1H2 (0.73) NR1H2NR1H3RXRAPTGER4PPARG
SCHEMBL5067204 0.77 NR1H2 (0.68) NR1H2NR1H3RXRAMEN1KMT2A
SCHEMBL1678599 0.76 NR1H2 (0.85) NR1H2NR1H3RXRAPTGER4PPARG
SCHEMBL1679118 0.76 NR1H2 (0.78) NR1H2NR1H3RXRAPTGER4PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923573-B2 Benzene compound having 2 or more substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-04-12 US disclosed
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255111-A1 Tissue Factor Production Inhibitor PTAFR, PLAT, TFPI NR1H2 7/4885NR1H3 6/4885RXRA 84/4885
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 NR1H2 1/4885NR1H3 2/4885RXRA 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.